Pelvic organ prolapse repair with and without prophylactic concomitant Burch colposuspension in continent women: A randomized, controlled trial with 8-year followup

Elisabetta Costantini, Massimo Lazzeri, Vittorio Bini, Michele Del Zingaro, Alessandro Zucchi, Massimo Porena

Research output: Contribution to journalArticle

40 Citations (Scopus)

Abstract

Purpose: We reevaluated and brought up to date the 8-year followup of a previous published, randomized, controlled trial of the impact of Burch colposuspension as a prophylactic anti-incontinence procedure in patients without urinary incontinence who underwent abdominal pelvic organ prolapse repair. Materials and Methods: A total of 66 continent women with pelvic organ prolapse were randomly assigned to abdominal pelvic organ prolapse repair and concomitant Burch colposuspension in 34 (group 1) or pelvic organ prolapse repair alone without an anti-incontinence procedure in 32 (group 2). Primary study end points were the anatomical outcome and changes in incontinence status. Secondary end points were changes in subjective symptoms and quality of life. Results: Median followup was 97 months (range 72 to 134). Three group 1 and 1 group 2 patients were lost to followup. Three group 1 patients had a stage I rectocele and 1 had a stage I cystocele. Four group 2 patients had a stage I rectocele and 3 had a stage I cystocele. Nine of 31 group 1 patients (29%) were incontinent compared with 5 of 31 (16%) in group 2 (p = 0.553). In group 1 all except 1 patient were successfully treated for voiding dysfunction. Storage symptoms had disappeared in 1 patient and de novo storage symptoms had developed in 2 since the previous followup. De novo incontinence developed in 2 group 2 patients after midterm outcomes were reported. Median Urogenital Distress Inventory-6 and Incontinence Impact on Quality of Life-7 scores were improved in all groups at last followup (p 0.0001). Conclusions: Long-term results cast doubt on whether Burch colposuspension should be done during pelvic organ prolapse repair in continent women.

Original languageEnglish
Pages (from-to)2236-2240
Number of pages5
JournalJournal of Urology
Volume185
Issue number6
DOIs
Publication statusPublished - Jun 2011

Fingerprint

Pelvic Organ Prolapse
Randomized Controlled Trials
Rectocele
Cystocele
Quality of Life
Urinary Incontinence
Equipment and Supplies

Keywords

  • pelvic organ prolapse
  • suburethral slings
  • treatment failure
  • urethra
  • urinary incontinence

ASJC Scopus subject areas

  • Urology

Cite this

Pelvic organ prolapse repair with and without prophylactic concomitant Burch colposuspension in continent women : A randomized, controlled trial with 8-year followup. / Costantini, Elisabetta; Lazzeri, Massimo; Bini, Vittorio; Del Zingaro, Michele; Zucchi, Alessandro; Porena, Massimo.

In: Journal of Urology, Vol. 185, No. 6, 06.2011, p. 2236-2240.

Research output: Contribution to journalArticle

Costantini, Elisabetta ; Lazzeri, Massimo ; Bini, Vittorio ; Del Zingaro, Michele ; Zucchi, Alessandro ; Porena, Massimo. / Pelvic organ prolapse repair with and without prophylactic concomitant Burch colposuspension in continent women : A randomized, controlled trial with 8-year followup. In: Journal of Urology. 2011 ; Vol. 185, No. 6. pp. 2236-2240.
@article{adaa2afcc0cf47a5bdeeab59106af21d,
title = "Pelvic organ prolapse repair with and without prophylactic concomitant Burch colposuspension in continent women: A randomized, controlled trial with 8-year followup",
abstract = "Purpose: We reevaluated and brought up to date the 8-year followup of a previous published, randomized, controlled trial of the impact of Burch colposuspension as a prophylactic anti-incontinence procedure in patients without urinary incontinence who underwent abdominal pelvic organ prolapse repair. Materials and Methods: A total of 66 continent women with pelvic organ prolapse were randomly assigned to abdominal pelvic organ prolapse repair and concomitant Burch colposuspension in 34 (group 1) or pelvic organ prolapse repair alone without an anti-incontinence procedure in 32 (group 2). Primary study end points were the anatomical outcome and changes in incontinence status. Secondary end points were changes in subjective symptoms and quality of life. Results: Median followup was 97 months (range 72 to 134). Three group 1 and 1 group 2 patients were lost to followup. Three group 1 patients had a stage I rectocele and 1 had a stage I cystocele. Four group 2 patients had a stage I rectocele and 3 had a stage I cystocele. Nine of 31 group 1 patients (29{\%}) were incontinent compared with 5 of 31 (16{\%}) in group 2 (p = 0.553). In group 1 all except 1 patient were successfully treated for voiding dysfunction. Storage symptoms had disappeared in 1 patient and de novo storage symptoms had developed in 2 since the previous followup. De novo incontinence developed in 2 group 2 patients after midterm outcomes were reported. Median Urogenital Distress Inventory-6 and Incontinence Impact on Quality of Life-7 scores were improved in all groups at last followup (p 0.0001). Conclusions: Long-term results cast doubt on whether Burch colposuspension should be done during pelvic organ prolapse repair in continent women.",
keywords = "pelvic organ prolapse, suburethral slings, treatment failure, urethra, urinary incontinence",
author = "Elisabetta Costantini and Massimo Lazzeri and Vittorio Bini and {Del Zingaro}, Michele and Alessandro Zucchi and Massimo Porena",
year = "2011",
month = "6",
doi = "10.1016/j.juro.2011.01.078",
language = "English",
volume = "185",
pages = "2236--2240",
journal = "Journal of Urology",
issn = "0022-5347",
publisher = "Elsevier Inc.",
number = "6",

}

TY - JOUR

T1 - Pelvic organ prolapse repair with and without prophylactic concomitant Burch colposuspension in continent women

T2 - A randomized, controlled trial with 8-year followup

AU - Costantini, Elisabetta

AU - Lazzeri, Massimo

AU - Bini, Vittorio

AU - Del Zingaro, Michele

AU - Zucchi, Alessandro

AU - Porena, Massimo

PY - 2011/6

Y1 - 2011/6

N2 - Purpose: We reevaluated and brought up to date the 8-year followup of a previous published, randomized, controlled trial of the impact of Burch colposuspension as a prophylactic anti-incontinence procedure in patients without urinary incontinence who underwent abdominal pelvic organ prolapse repair. Materials and Methods: A total of 66 continent women with pelvic organ prolapse were randomly assigned to abdominal pelvic organ prolapse repair and concomitant Burch colposuspension in 34 (group 1) or pelvic organ prolapse repair alone without an anti-incontinence procedure in 32 (group 2). Primary study end points were the anatomical outcome and changes in incontinence status. Secondary end points were changes in subjective symptoms and quality of life. Results: Median followup was 97 months (range 72 to 134). Three group 1 and 1 group 2 patients were lost to followup. Three group 1 patients had a stage I rectocele and 1 had a stage I cystocele. Four group 2 patients had a stage I rectocele and 3 had a stage I cystocele. Nine of 31 group 1 patients (29%) were incontinent compared with 5 of 31 (16%) in group 2 (p = 0.553). In group 1 all except 1 patient were successfully treated for voiding dysfunction. Storage symptoms had disappeared in 1 patient and de novo storage symptoms had developed in 2 since the previous followup. De novo incontinence developed in 2 group 2 patients after midterm outcomes were reported. Median Urogenital Distress Inventory-6 and Incontinence Impact on Quality of Life-7 scores were improved in all groups at last followup (p 0.0001). Conclusions: Long-term results cast doubt on whether Burch colposuspension should be done during pelvic organ prolapse repair in continent women.

AB - Purpose: We reevaluated and brought up to date the 8-year followup of a previous published, randomized, controlled trial of the impact of Burch colposuspension as a prophylactic anti-incontinence procedure in patients without urinary incontinence who underwent abdominal pelvic organ prolapse repair. Materials and Methods: A total of 66 continent women with pelvic organ prolapse were randomly assigned to abdominal pelvic organ prolapse repair and concomitant Burch colposuspension in 34 (group 1) or pelvic organ prolapse repair alone without an anti-incontinence procedure in 32 (group 2). Primary study end points were the anatomical outcome and changes in incontinence status. Secondary end points were changes in subjective symptoms and quality of life. Results: Median followup was 97 months (range 72 to 134). Three group 1 and 1 group 2 patients were lost to followup. Three group 1 patients had a stage I rectocele and 1 had a stage I cystocele. Four group 2 patients had a stage I rectocele and 3 had a stage I cystocele. Nine of 31 group 1 patients (29%) were incontinent compared with 5 of 31 (16%) in group 2 (p = 0.553). In group 1 all except 1 patient were successfully treated for voiding dysfunction. Storage symptoms had disappeared in 1 patient and de novo storage symptoms had developed in 2 since the previous followup. De novo incontinence developed in 2 group 2 patients after midterm outcomes were reported. Median Urogenital Distress Inventory-6 and Incontinence Impact on Quality of Life-7 scores were improved in all groups at last followup (p 0.0001). Conclusions: Long-term results cast doubt on whether Burch colposuspension should be done during pelvic organ prolapse repair in continent women.

KW - pelvic organ prolapse

KW - suburethral slings

KW - treatment failure

KW - urethra

KW - urinary incontinence

UR - http://www.scopus.com/inward/record.url?scp=79955815882&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79955815882&partnerID=8YFLogxK

U2 - 10.1016/j.juro.2011.01.078

DO - 10.1016/j.juro.2011.01.078

M3 - Article

C2 - 21497843

AN - SCOPUS:79955815882

VL - 185

SP - 2236

EP - 2240

JO - Journal of Urology

JF - Journal of Urology

SN - 0022-5347

IS - 6

ER -